Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Successful treatment of IgG-4 related sclerosing disease with rituximab: a novel case report.

Gillispie MC, Thomas RD, Hennon TR.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):549-50. Epub 2015 Apr 16.

PMID:
25897489
2.

Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors.

Gatson NN, Williams JL, Powell ND, McClain MA, Hennon TR, Robbins PD, Whitacre CC.

J Neuroimmunol. 2011 Jan;230(1-2):105-13. doi: 10.1016/j.jneuroim.2010.09.010. Epub 2010 Oct 14.

3.

The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, Punaro M, Rabinovich EC, Rosenkranz M, Kietz DA, Rosen P, Spalding SJ, Hennon TR, Torok KS, Cassidy E, Medsger TA Jr; Localized Scleroderma Clinical and Ultrasound Study Group.

J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.

4.

Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices.

Gerschultz KL, Sucato GS, Hennon TR, Murray PJ, Gold MA.

J Adolesc Health. 2007 Feb;40(2):151-7. Epub 2006 Nov 29.

PMID:
17259055

Supplemental Content

Loading ...
Support Center